Ontology highlight
ABSTRACT:
SUBMITTER: Skripconoka V
PROVIDER: S-EPMC3669462 | biostudies-literature | 2013 Jun
REPOSITORIES: biostudies-literature
Skripconoka Vija V Danilovits Manfred M Pehme Lea L Tomson Tarmo T Skenders Girts G Kummik Tiina T Cirule Andra A Leimane Vaira V Kurve Anu A Levina Klavdia K Geiter Lawrence J LJ Manissero Davide D Wells Charles D CD
The European respiratory journal 20120927 6
Multidrug-resistant and extensively drug-resistant tuberculosis (TB) are associated with worse treatment outcomes for patients, including higher mortality, than for drug-sensitive tuberculosis. Delamanid (OPC-67683) is a novel anti-TB medication with demonstrated activity against multidrug-resistant disease. Patients who participated in the previously reported randomised, placebo-controlled trial of delamanid and the subsequent open-label extension trial were eligible to participate in a 24-mont ...[more]